The NSW Government is expanding the medicinal cannabis trial for chemotherapy patients to seven more hospitals across the state.
The world-first trial for the prevention of chemotherapy-induced nausea and vomiting will use new generation anti-nausea products alongside cannabis products.
The trial looks at how a cannabis product can assist with nausea where standard treatments have failed.
Professor John Simes, director of the National Health and Medical Research Council (NHMRC) Clinical Trials Centre, said due to the very limited evidence worldwide, it’s not known whether cannabis products may be able to help these patients where other medications have not. “This study aims to provide a definitive answer to that question,” he said.
To view the Review of the Medicinal Cannabis Compassionate Use Scheme report visit: bit.ly/2qlHzKY